王惠芹, 王真真, 陈乃宏. 抑郁症发病与受体基因异常研究进展J. 药学学报, 2020,55(3): 384-391. doi: 10.16438/j.0513-4870.2019-0600
引用本文: 王惠芹, 王真真, 陈乃宏. 抑郁症发病与受体基因异常研究进展J. 药学学报, 2020,55(3): 384-391. doi: 10.16438/j.0513-4870.2019-0600
WANG Hui-qin, WANG Zhen-zhen, CHEN Nai-hong. Advance in relationship between receptor gene abnormality and depressionJ. Acta Pharmaceutica Sinica, 2020,55(3): 384-391. doi: 10.16438/j.0513-4870.2019-0600
Citation: WANG Hui-qin, WANG Zhen-zhen, CHEN Nai-hong. Advance in relationship between receptor gene abnormality and depressionJ. Acta Pharmaceutica Sinica, 2020,55(3): 384-391. doi: 10.16438/j.0513-4870.2019-0600

抑郁症发病与受体基因异常研究进展

Advance in relationship between receptor gene abnormality and depression

  • 摘要: 抑郁症是一种以心境低落、悲观厌世、认知和睡眠障碍为主要特征的慢性综合征,临床上具有高发病率、高自杀率和低就诊率、低治疗率的特点。抑郁症发病40%~50%的风险来自基因。因此,研究基因异常是研究抑郁症发病内在原因的重要部分,其中受体基因异常是导致抑郁症发病的重要因素。研究潜在的受体基因位点有望成为未来抑郁症治疗的新靶点,能够为抑郁症的早期诊断、预防和治疗提供理论依据。

     

    Abstract: Depression, a chronic syndrome with low mood, pessimism, cognitive and sleep disorders, is characterized by high incidence, high suicide rate, low consultation and treatment rate. 40%-50% of the risk of depression comes from genes, so studying on gene abnormalities serves as an important part of the research in the internal causes of depression, among which the receptor gene abnormalities are crucial factors. The study of potential receptor gene loci is expected to be new target for the treatment of depression in the future, which can provide theoretical basis for the early diagnosis, prevention and treatment of depression.

     

/

返回文章
返回